ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

被引：850

作者：

Gennari, A. ^{[1
]}

Andre, F. ^{[2
]}

Barrios, C. H. ^{[3
]}

Cortes, J. ^{[4
,5
,6
,7
]}

de Azambuja, E. ^{[8
,9
]}

DeMichele, A. ^{[10
]}

Dent, R. ^{[11
]}

Fenlon, D. ^{[12
]}

Gligorov, J. ^{[13
]}

Hurvitz, S. A. ^{[14
,15
]}

Im, S. -a. ^{[16
]}

Krug, D. ^{[17
]}

Kunz, W. G. ^{[18
]}

Loi, S. ^{[19
]}

Penault-Llorca, F. ^{[20
]}

Ricke, J. ^{[2
,18
]}

Robson, M. ^{[21
]}

Rugo, H. S. ^{[22
]}

Saura, C. ^{[23
]}

Schmid, P. ^{[24
]}

Singer, C. F. ^{[25
,26
]}

Spanic, T. ^{[27
]}

Tolaney, S. M. ^{[28
]}

Turner, N. C. ^{[29
]}

Curigliano, G. ^{[30
,31
]}

Loibl, S. ^{[32
]}

Paluch-Shimon, S. ^{[33
,34
]}

Harbeck, N. ^{[35
,36
]}

机构：

[1] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy

[2] Gustave Roussyd Canc Campus, Dept Med Oncol, Breast Canc Unit, Villejuif, France

[3] Grp Oncoclin, Oncol Res Ctr, Porto Alegre, RS, Brazil

[4] Quironsalud Grp, Int Breast Canc Ctr IBCC, Barcelona, Spain

[5] Med Sci Innovat Res, Sci Dept, Valencia, Spain

[6] Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[7] Univ Europea Madrid, Fac Biomed & Hlth Sci, Dept Med, Madrid, Spain

[8] Inst Jules Bordet, Med Oncol Dept, Brussels, Belgium

[9] Univ Libre Bruxelles L B, Brussels, Belgium

[10] Hosp Univ Penn, Hematol Oncol Dept, 3400 Spruce St, Philadelphia, PA 19104 USA

[11] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore

[12] Swansea Univ, Coll Human & Hlth Sci, Singleton Pk Campus, Swansea, W Glam, Wales

[13] Sorbonne Univ, Hop Tenon, AP HP, Dept Oncol Med,Inst Univ Cancerol, Paris, France

[14] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA

[15] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA

[16] Seoul Natl Univ, Seoul Natl Univ Hosp, Canc Res Inst, Dept Internal Med,Coll Med, Seoul, South Korea

[17] Univ Hosp Schleswig Holsteind Campus Kiel, Dept Radiat Oncol, Kiely, Germany

[18] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany

[19] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[20] Univ Clermont Auvergne, Ctr Lutte Canc Jean Perrin Imagerie Mol & Strateg, INSERM, UMR,UCA, Clermont Ferrand, France

[21] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[22] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[23] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Breast Canc Program, Barcelona, Spain

[24] Barts & London Queen Marys Sch Med & Dent, Canc Res UK Barts Ctr, Ctr Expt Canc Med, London, England

[25] Med Univ Vienna, Ctr Breast Hlth, Vienna, Austria

[26] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria

[27] Europa Donna Slovenia, Ljubljana, Slovenia

[28] Dana Farber Canc Inst, Boston, MA 02115 USA

[29] Royal Marsden Hosp NHS Fdn Trust, London, England

[30] IRCCS, Ist Europeo Oncol, Early Drug Dev Innovat Therapies Div, Milan, Italy

[31] Univ Milan, Milan, Italy

[32] GBG Forschungs GmbH, Neu Isenburg, Germany

[33] Hadassah Univ Hosp, Sharett Inst Oncol Dept, Jerusalem, Israel

[34] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel

[35] LMU Univ Hosp, Dept Obstet & Gynecol, Breast Ctr, Munich, Germany

[36] LMU Univ Hosp, Comprehens Canc Ctr Munich, Munich, Germany

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷 / 12期

关键词：

diagnosis; ESCAT; ESMO Clinical Practice Guideline; ESMO-MCBS; metastatic breast cancer; treatment; INTERNATIONAL CONSENSUS GUIDELINES; ALPELISIB PLUS FULVESTRANT; GERMLINE BRCA MUTATION; DOUBLE-BLIND; OPEN-LABEL; PHYSICIANS CHOICE; SACITUZUMAB GOVITECAN; TRASTUZUMAB EMTANSINE; REPORTED OUTCOMES; ENDOCRINE THERAPY;

D O I：

10.1016/j.annonc.2021.09.019

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1475 / 1495

页数：21

共 93 条

[1] Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer [J].

Accordino, Melissa K. ;

Wright, Jason D. ;

Vasan, Sowmya ;

Neugut, Alfred I. ;

Hillyer, Grace C. ;

Hu, Jim C. ;

Hershman, Dawn L. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) :2820-+

[2] Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].

Allemani, Claudia ;

Matsuda, Tomohiro ;

Di Carlo, Veronica ;

Harewood, Rhea ;

Matz, Melissa ;

Niksic, Maja ;

Bonaventure, Audrey ;

Valkov, Mikhail ;

Johnson, Christopher J. ;

Esteve, Jacques ;

Ogunbiyi, Olufemi J. ;

Azevedo e Silva, Gulnar ;

Chen, Wan-Qing ;

Eser, Sultan ;

Engholm, Gerda ;

Stiller, Charles A. ;

Monnereau, Alain ;

Woods, Ryan R. ;

Visser, Otto ;

Lim, Gek Hsiang ;

Aitken, Joanne ;

Weir, Hannah K. ;

Coleman, Michel P. .

LANCET, 2018, 391 (10125) :1023-1075

[3] Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2enegative advanced breast cancer: final overall survival results from SOLAR-1 [J].

Andre, F. ;

Ciruelos, E. M. ;

Juric, D. ;

Loibl, S. ;

Campone, M. ;

Mayer, I. A. ;

Rubovszky, G. ;

Yamashita, T. ;

Kaufman, B. ;

Lu, Y-S ;

Inoue, K. ;

Papai, Z. ;

Takahashi, M. ;

Ghaznawi, F. ;

Mills, D. ;

Kaper, M. ;

Miller, M. ;

Conte, P. F. ;

Iwata, H. ;

Rugo, H. S. .

ANNALS OF ONCOLOGY, 2021, 32 (02) :208-217

[4] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer [J].

Andre, Fabrice ;

Ciruelos, Eva ;

Rubovszky, Gabor ;

Campone, Mario ;

Loibl, Sibylle ;

Rugo, Hope S. ;

Iwata, Hiroji ;

Conte, Pierfranco ;

Mayer, Ingrid A. ;

Kaufman, Bella ;

Yamashita, Toshinari ;

Lu, Yen-Shen ;

Inoue, Kenichi ;

Takahashi, Masato ;

Papai, Zsuzsanna ;

Longin, Anne-Sophie ;

Mills, David ;

Wilke, Celine ;

Hirawat, Samit ;

Juric, Dejan .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) :1929-1940

[5]

[Anonymous], 2020, EMA Recommendations on DPD Testing Prior to Treatment with Fluorouracil, Capecitabine, Tegafur and Flucytosine, V31, P3

[6] Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial [J].

Bachelot, Thomas ;

Filleron, Thomas ;

Bieche, Ivan ;

Arnedos, Monica ;

Campone, Mario ;

Dalenc, Florence ;

Coussy, Florence ;

Sablin, Marie-Paule ;

Debled, Marc ;

Lefeuvre-Plesse, Claudia ;

Goncalves, Anthony ;

Reynier, Marie-Ange Mouret ;

Jacot, William ;

You, Benoit ;

Barthelemy, Philippe ;

Verret, Benjamin ;

Isambert, Nicolas ;

Tchiknavorian, Xavier ;

Levy, Christelle ;

Thery, Jean-Christophe ;

L'Haridon, Tifenn ;

Ferrero, Jean-Marc ;

Mege, Alice ;

Del Piano, Francesco ;

Rouleau, Etienne ;

Tran-Dien, Alicia ;

Adam, Julien ;

Lusque, Amelie ;

Jimenez, Marta ;

Jacquet, Alexandra ;

Garberis, Ingrid ;

Andre, Fabrice .

NATURE MEDICINE, 2021, 27 (02) :250-+

[7] Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial [J].

Bardia, A. ;

Messersmith, W. A. ;

Kio, E. A. ;

Berlin, J. D. ;

Vahdat, L. ;

Masters, G. A. ;

Moroose, R. ;

Santin, A. D. ;

Kalinsky, K. ;

Picozzi, V ;

O'Shaughnessy, J. ;

Gray, J. E. ;

Komiya, T. ;

Lang, J. M. ;

Chang, J. C. ;

Starodub, A. ;

Goldenberg, D. M. ;

Sharkey, R. M. ;

Maliakal, P. ;

Hong, Q. ;

Wegener, W. A. ;

Goswami, T. ;

Ocean, A. J. .

ANNALS OF ONCOLOGY, 2021, 32 (06) :746-756

[8] Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer [J].

Bardia, A. ;

Hurvitz, S. A. ;

Tolaney, S. M. ;

Loirat, D. ;

Punie, K. ;

Oliveira, M. ;

Brufsky, A. ;

Sardesai, S. D. ;

Kalinsky, K. ;

Zelnak, A. B. ;

Weaver, R. ;

Traina, T. ;

Dalenc, F. ;

Aftimos, P. ;

Lynce, F. ;

Diab, S. ;

Cortes, J. ;

O'Shaughnessy, J. ;

Dieras, V ;

Ferrario, C. ;

Schmid, P. ;

Carey, L. A. ;

Gianni, L. ;

Piccart, M. J. ;

Loibl, S. ;

Goldenberg, D. M. ;

Hong, Q. ;

Olivo, M. S. ;

Itri, L. M. ;

Rugo, H. S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16) :1529-1541

[9] Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer [J].

Baselga, Jose ;

Campone, Mario ;

Piccart, Martine ;

Burris, Howard A., III ;

Rugo, Hope S. ;

Sahmoud, Tarek ;

Noguchi, Shinzaburo ;

Gnant, Michael ;

Pritchard, Kathleen I. ;

Lebrun, Fabienne ;

Beck, J. Thaddeus ;

Ito, Yoshinori ;

Yardley, Denise ;

Deleu, Ines ;

Perez, Alejandra ;

Bachelot, Thomas ;

Vittori, Luc ;

Xu, Zhiying ;

Mukhopadhyay, Pabak ;

Lebwohl, David ;

Hortobagyi, Gabriel N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06) :520-529

[10] Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer [J].

Baselga, Jose ;

Cortes, Javier ;

Kim, Sung-Bae ;

Im, Seock-Ah ;

Hegg, Roberto ;

Im, Young-Hyuck ;

Roman, Laslo ;

Pedrini, Jose Luiz ;

Pienkowski, Tadeusz ;

Knott, Adam ;

Clark, Emma ;

Benyunes, Mark C. ;

Ross, Graham ;

Swain, Sandra M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) :109-119

← 1 2 3 4 5 6 7 8 9 10 →